Target intelligence / Profile preview

POM121 transmembrane nucleoporin C pseudogene

Molecular classification
Other (pseudogene; does not produce functional protein)
01

Overview

The *POM121 transmembrane nucleoporin C pseudogene* is a genomic locus similar to the POM121 family of genes, which produce transmembrane nucleoporin proteins essential for the assembly and function of the nuclear pore complex (NPC)[2][5][7]. However, by definition as a pseudogene, ENSG00000271071 is not protein-coding and is not considered a valid therapeutic target, classically understood as a receptor, enzyme, transporter, or transcription factor. Pseudogenes often arise following gene duplication or mutation and can be markers of evolutionary processes but typically do not exhibit biological activity or direct involvement in disease; however, their functional relatives (such as *POM121*, *POM121C*) are essential nuclear pore complex components, affecting cell cycle, nucleocytoplasmic transport, and associated with cancer and metabolic disease[1][2][3]. The presence of "pseudogene" in this locus name and lack of evidence in the search results for any encoded protein or drug interaction means it is not a valid target[5][7]. Note: If you intended a protein-coding nucleoporin, refer to *POM121* or *POM121C*, not the pseudogene. If you require information about the protein-coding gene *POM121C*, see the corresponding entries (ENSG00000272391)[2].

Other names
POM121 membrane glycoprotein B (pseudogene)POM121L1P
02

Biological functions

Other (pseudogenes often do not have a known biological function)
03

Disease associations

Other (no direct disease association; POM121 functional genes are linked to cancer, Williams-Beuren syndrome, etc.[1][2])

Beyond the preview

Go deeper on POM121 transmembrane nucleoporin C pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POM121 transmembrane nucleoporin C pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call